In a recent LinkedIn post, Dr. Martha Boeckenfeld highlights a groundbreaking approach to treating stroke patients, detailing how researchers are using personalized microfluidic models to understand and combat recurrent strokes. Dr. Boeckenfeld shares the story of a 67-year-old patient who continued to suffer strokes despite being on blood-thinning medication. This case prompted researchers at the University of Sydney to investigate the underlying causes.
As Dr. Boeckenfeld explains, the key to understanding this patient’s condition lay in recreating his unique anatomy. PhD researcher Yunduo Charles Zhao and Associate Professor Lining Arnold Ju developed an innovative method:
“Zhao scaled the vessel down 30-fold and printed it as a microfluidic channel on a glass slide in under two hours. Then they ran the patient’s own blood through it.”
This personalized model revealed critical insights that standard protocols had overlooked. Dr. Boeckenfeld points out that the patient’s treatment had primarily focused on the degree of arterial blockage. However, the microfluidic replica exposed a different issue.
Unveiling Clotting Triggers Through Personalized Models
Dr. Boeckenfeld elaborates on how the patient’s specific artery shape, not just the blockage, contributed to the problem. The unique geometry created areas where blood flow became extremely turbulent, leading to the formation of clots even while the patient was on medication. This turbulence, as described by Dr. Boeckenfeld, specifically triggered clotting in areas where shear stress exceeded a critical threshold.
“The replica exposed another problem: the shape of his artery created areas of extreme blood flow that triggered clotting despite the medication.”
The researchers leveraged this personalized chip to test various treatments directly with the patient’s blood. This allowed them to identify the most effective blood-thinning and clot-busting drugs for his specific condition, ultimately helping to stabilize him. Dr. Boeckenfeld emphasizes the significance of this personalized testing phase.
The Power of Individualized Medicine
The post also touches upon the personal motivations driving this research. Dr. Boeckenfeld shares that Yunduo Charles Zhao’s interest in cardiovascular disease stems from personal family history, including a grandfather’s heart attack and a grandmother’s stroke. This deep-seated connection fuels Zhao’s dedication to developing more individualized treatment strategies.
“His aim is simple: test a treatment against a patient’s own blood and vessel anatomy before relying on it inside the body.”
Dr. Boeckenfeld concludes by posing a critical question to her audience, prompting reflection on the limitations of standard protocols when faced with individual variations. This highlights a broader trend in medicine towards more personalized and precise interventions.
“Where have you seen a standard protocol fail because the individual case behaved differently from the average?”
The work by Zhao, Ju, and their colleagues, as shared by Dr. Boeckenfeld, represents a significant step forward in cardiovascular medicine, showcasing how advanced bioengineering and personalized approaches can overcome the shortcomings of one-size-fits-all treatments and offer new hope for patients with complex conditions like recurrent strokes.
📝 About This Content
This article is based on insights shared by Dr. Martha Boeckenfeld on LinkedIn.
📅 Originally posted on September 14, 2026 | View original post on LinkedIn →